Cerebral oxygenation and haemodynamic effects induced by nimodipine in healthy subjects

Functional Neurology

Volumn 27, Issue 3, 2012, Pages 169-176

  Canova, Daniela ^a   Roatta, Silvestro ^b   Micieli, Giuseppe ^a   Bosone, Daniele ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cerebral blood flow; Hyperventilation; Near infrared spectroscopy; Nimodipine; Rebreathing

Indexed keywords

HEMOGLOBIN; NIMODIPINE; OXYHEMOGLOBIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; BLOOD VOLUME; BRAIN ARTERY; BRAIN TISSUE; BRAIN VASCULAR RESISTANCE; CLINICAL TRIAL; DIZZINESS; DOPPLER ECHOGRAPHY; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HEADACHE; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; HYPERVENTILATION; MALE; NEAR INFRARED SPECTROSCOPY; NORMAL HUMAN; PERFUSION; REBREATHING; TISSUE OXYGENATION; VASODILATATION;

ADULT; ARTERIAL PRESSURE; BLOOD FLOW VELOCITY; BLOOD VOLUME; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR CIRCULATION; FEMALE; HEMODYNAMICS; HUMANS; HYPERVENTILATION; ITALY; MALE; NIMODIPINE; OXYGEN CONSUMPTION; SPECTROSCOPY, NEAR-INFRARED; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84873618541     PISSN: 03935264     EISSN: 19713274     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Buggy DJ, Asher MJ, Lambert DG. Nimodipine premedication and induction dose of propofol. Anesth Analg 2000;90:445-449.
2. Uchida S, Yamada S, Nagai K, Deguchi Y, Kimura R. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists. Life Sci 1997;61:2083-2090.
3. van den Kerckhoff W, Drewes LR. Transfer of the Ca-antagonists nifedipine and nimodipine across the blood-brain barrier and their regional distribution in vivo. J Cereb Blood Flow Metab 1985;5 S1:S459-S460.
4. Alborch E, Salom JB, Torregrosa G. Calcium channels in cerebral arteries. Pharmacol Ther 1995;68:1-34.
5. Langley MS, Sorkin EM. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 1989;37:669-699.
6. Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens 2008;30:744-766.
7. Pasternak JJ, Lanier WL. Neuroanesthesiology update. J Neurosurg Anesthesiol 2010;22:86-109.
8. Araie M, Mayama C. Use of calcium channel blockers for glaucoma. Prog Retin Eye Res 2011;30:54-71.
9. Velat GJ, Kimball MM, Mocco JD, Hoh BL. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg 2011;76:446-454.
10. Keyrouz SG, Diringer MN. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 2007;11:220.
11. Stork CJ, Li YV. Rising zinc: a significant cause of ischemic neuronal death in the CA1 region of rat hippocampus. J Cereb Blood Flow Metab. 2009;29:1399-1408.
12. Babu CS, Ramanathan M. Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics. Int J Dev Neurosci 2011;29:93-105.
13. O'Brien JT. Vascular cognitive impairment. Am J Geriatr Psychiatry 2006;14:724-733.
14. Baskys A, Hou AC. Vascular dementia: pharmacological treatment approaches and perspectives. Clin Interv Aging 2007;2:327-235.
15. Lopez-Arrieta JM, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev 2002;(3):CD000147.
16. Pantoni L, del Ser T, Soglian AG et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial. Stroke 2005;36:619-624.
17. McCalden TA, Nath RG. Cerebrovascular autoregulation is resistant to calcium channel blockade with nimodipine. Experientia 1989;45:305-306.
18. Schmidt JF, Waldemar G. Effect of nimodipine on cerebral blood flow in human volunteers. J Cardiovasc Pharmacol. 1990;16:568-571.
19. Tzeng YC, Chan GS, Willie CK, Ainslie PN. Determinants of human cerebral pressure-flow velocity relationships: new insights from vascular modelling and Ca2+ channel blockade. J Physiol 2011;589:3263-3274.
20. Schmidt JF, Waldemar G, Paulson OB. The acute effect of nimodipine on cerebral blood flow, its CO2 reactivity, and cerebral oxygen metabolism in human volunteers. Acta Neurochir (Wien) 1991;111:49-53.
21. Al-Rawi PG, Smielewski P, Kirkpatrick PJ. Evaluation of a near-infrared spectrometer (NIRO 300) for the detection of intracranial oxygenation changes in the adult head. Stroke 2001;32:2492-2500.
22. Canova D, Roatta S, Bosone D, Micieli G. Inconsistent detection of changes in cerebral blood volume by near infrared spectroscopy in standard clinical tests. J Appl Physiol 2011;110:1646-1655.
23. Cummings KJ, Swart M, Ainslie PN. Morning attenuation in cerebrovascular CO2 reactivity in healthy humans is associated with a lowered cerebral oxygenation and an augmented ventilatory response to CO2. J Appl Physiol 2007 May;102:1891-1898.
24. Vernieri F, Tibuzzi F, Pasqualetti P et al. Transcranial Doppler and near-infrared spectroscopy can evaluate the hemodynamic effect of carotid artery occlusion. Stroke 2004;35:64-70.
25. Terborg C, Birkner T, Schack B, Weiller C, Rother J. Noninvasive monitoring of cerebral oxygenation during vasomotor reactivity tests by a new near-infrared spectroscopy device. Cerebrovasc Dis 2003;16:36-41.
26. Muller-Schweinitzer E, Neumann P. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries. J Cereb Blood Flow Metab 1983;3:354-361.
27. Allen GS. Role of calcium antagonists in cerebral arterial spasm. Am J Cardiol 1985;55:149B-153B.
28. Nosko M, Krueger CA, Weir BK, Cook DA. Effects of nimodipine on in vitro contractility of cerebral arteries of dog, monkey, and man. J Neurosurg 1986;65:376-381.
29. Forsman M, Fleischer JE, Milde JH, Steen PA, Michenfelder JD. The effects of nimodipine on cerebral blood flow and metabolism. J Cereb Blood Flow Metab 1986;6:763-767.
30. van der Giessen WJ, Duncker DJ, Saxena PR, Verdouw PD. Nimodipine has no effect on the cerebral circulation in conscious pigs, despite an increase in cardiac output. Br J Pharmacol 1990;100:277-282.
31. Semkina GA, Matsievskii DD, Mirzoyan NR. Effect of pyrrolidone-pyroglutamic acid composition on blood flow in rat middle cerebral artery. Bull Exp Biol Med 2006;141:51-52.
32. Forsman M, Olsnes BT, Semb G, Steen PA. Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery. Br J Anaesth 1990;65: 514-520.
33. Kraaier V, van Huffelen AC, Wieneke GH, Hesselink JM. Nimodipine tested in a human model of cerebral ischaemia. Electroencephalographic and transcranial Doppler ultrasound investigations in normal subjects during standardized hyperventilation. Eur J Clin Pharmacol 1991;40:17-21.
34. Gemici K, Baran I, Bakar M, Demircan C, Ozdemir B, Cordan J. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis. Blood Press 2003;12:46-48.
35. Roatta S, Micieli G, Bosone D et al. Effect of generalized sympathetic activation by cold pressor test on cerebral haemodynamics in healthy humans. J Auton Nerv Syst 1998;71:159-166.
36. Choi SH, Lee SJ, Jung YS et al. Nitroglycerin- and nicardipine-induced hypotension does not affect cerebral oxygen saturation and postoperative cognitive function in patients undergoing orthognathic surgery. J Oral Maxillofac Surg 2008;66:2104-2109.
37. Morimoto Y, Kemmotsu O, Gando S, Shibano T, Shikama H. The effect of calcium channel blockers on cerebral oxygenation during tracheal extubation. Anesth Analg 2000; 91:347-352.
38. Haws CW, Gourley JK, Heistad DD. Effects of nimodipine on cerebral blood flow. J Pharmacol Exp Ther 1983;225: 24-28.
39. McCalden TA, Nath RG, Thiele K. The effects of a calcium antagonist (nimodipine) on basal cerebral blood flow and reactivity to various agonists. Stroke 1984;15:527-530.
40. Stiefel MF, Heuer GG, Abrahams JM et al. The effect of nimodipine on cerebral oxygenation in patients with poorgrade subarachnoid hemorrhage. J Neurosurg 2004;101: 594-599.
41. Seiler RW, Nirkko AC. Effect of nimodipine on cerebrovascular response to CO2 in asymptomatic individuals and patients with subarachnoid hemorrhage: a transcranial Doppler ultrasound study. Neurosurgery 1990;27:247-251.
42. Russo G, Lodi CA, Ursino M. Quantitative assessment of cerebral vascular reserve by means of transcranial Doppler ultrasound and rebreathing maneuver: bedside test and mathematical modeling. Neurol Sci 2000;21: 292-302.
43. Yoshitani K, Kawaguchi M, Tatsumi K, Kitaguchi K, Furuya H. A comparison of the INVOS 4100 and the NIRO 300 near-infrared spectrophotometers. Anesth Analg 2002;94: 586-590.
44. Grabowski M, Johansson BB. Nifedipine and nimodipine: effect on blood pressure and regional cerebral blood flow in conscious normotensive and hypertensive rats. J Cardiovasc Pharmacol 1985;7:1127-1133.